Advertisement

Topics

Search Results for "Cvs Minute Clinic Shingles Vaccine"

02:08 EDT 1st May 2016 | BioPortfolio

Matching Channels

Varicella

Varicella zoster virus (VZV) is one of eight herpes viruses known to infect humans (and other vertebrates). Varicella-zoster virus is known by many names, including: chickenpox virus, varicella viru...

HPV vaccine

Rotavirus Vaccine GSK

Smallpox Vaccine MVA

Poliovirus Vaccine OPV

Matching News

GSK’s candidate shingles vaccine demonstrates 90% efficacy against shingles in people 70 years of age and over

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the second pivotal phase III study of its candidate vaccine Shingrix™ in adults aged 70 years and over (known as ZOE-70) successfully met its...

BRIEF-GSK's shingles vaccine candidate shows 90 pct efficacy

* GSK's candidate shingles vaccine demonstrates 90 pct efficacy against shingles in people 70 years of age and over

Childhood asthma may increase risks of shingles

Nearly 1 million incidences of herpes zoster, which is also known as shingles, occur every year in the U.S., with an estimated one-third of all adults affected by age 80. Despite its prevalence, parti...

GSK’s candidate shingles vaccine demonstrates 90% efficacy against shingles

GSK's Shingles Vaccine Steps Closer To Catching Zostavax

The ZOE-70 study in 14,800 adults aged 70 years and over met its primary objective, demonstrating 90% (95% confidence interval: 84–94) efficacy against shingles compared with placebo.

Shingles increases short-term risk of stroke in older adults

More than 95% of the world's adult population is infected with the virus that causes chickenpox. Up to one third of these individuals will develop shingles (herpes zoster) in their lifetime. A new U.S...

GSK commences Phase III clinical trials to develop herpes zoster vaccine for the prevention of shingles

GlaxoSmithKline confirmed today that the company has commenced the Phase III clinical trials programme of its candidate herpes zoster vaccine currently being developed for the prevention of shingles. ...

Chickenpox, shingles vaccine may cause corneal inflammation in some patients

(University of Missouri-Columbia) In use for more than 20 years, the varicella zoster virus vaccine for chickenpox and shingles is considered an essential medicine by the World Health Organization (WH...

Matching PubMed Articles

Risk of Shingles in Adults with Primary Sjogren's Syndrome and Treatments: A Nationwide Population-Based Cohort Study.

Primary Sjögren's syndrome (pSS) is associated with immunological dysfunctions-a well-known risk factor of shingles. This study aimed to examine the incidence and risk of shingles in adults with pSS ...

Annual incidence rates of herpes zoster among an immunocompetent population in the United States.

Herpes zoster (HZ), also known as shingles, is a painful and commonly occurring condition in the United States. In spite of a universally recommended vaccine for use in immunocompetent adults aged 60...

Herpes Zoster Vaccine in the Long-Term Care Setting: A Clinical and Logistical Conundrum.

Advancing age is associated with an increased risk of herpes zoster (shingles) infection and latent effects such as postherpetic neuralgia. The herpes zoster vaccine is recommended in those 60 years o...

Rapid Screening for Cognitive Impairment in Parkinson's Disease: A Pilot Study.

Aim. This study sought to establish the discriminant validity of a rapid cognitive screen, that is, the National Institute of Neurological Disease and Stroke-Canadian Stroke Network (NINDS-CSN) 5-minu...

Lessons learned from making and implementing vaccine recommendations in the U.S.

After publication of certain vaccine recommendations made by the Advisory Committee on Immunization Practices, several unexpected events have occurred during implementation of these recommendations. T...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement